CIK 0001775194
- Non-accelerated filer
- Smaller reporting company
UPEXI, INC.
Sign in to watch- Ticker
- UPXI
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 833378978
- Phone
- +1 727-287-2800
- Business address
- 3030 N. ROCKY POINT DRIVE, SUITE 420, TAMPA, FL
- Former names
- GROVE, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-03 | Salkind Gene Director | Grant or award | +100,000 | 318,750 | ||
| 2025-11-20 | Salkind Gene Director | Purchase | +50,000 | $2.55 | $128K | 218,750 |
| 2025-11-17 | Salkind Gene Director | Purchase | +100,000 | $2.65 | $265K | 569,470 |
| 2025-11-17 | Salkind Gene Director | Purchase | +100,000 | $2.81 | $281K | 168,750 |
| 2025-07-16 | Salkind Gene Director | Grant or award | +50,000 | 435,370 | ||
| 2025-07-16 | Salkind Gene Director | Grant or award | +150,000 | 585,370 | ||
| 2025-07-11 | Salkind Gene Director | Purchase | +20,243 | $4.94 | $100K | 385,370 |
| 2025-04-17 | Salkind Gene Director | Purchase | +241,229 | $2.28 | $550K | 365,127 |
| 2025-04-17 | Salkind Gene Director | Grant or award · Options to buy common stock | +35,000 | 35,000 | ||
| 2025-01-17 | Salkind Gene Director | Grant or award · Options to buy common stock | +25,000 | 25,000 | ||
| 2022-09-30 | Salkind Gene Director | Grant or award · Stock Option Grant (right to buy) | +50,000 | 50,000 | ||
| 2022-03-30 | Salkind Gene Director | Purchase | +125,000 | $4.00 | $500K | 125,000 |
| 2021-07-21 | Salkind Gene Director | Grant or award · Option Grant | +50,000 | 50,000 |
Page 1 of 1 · 13 trades